Healthcare Inroads (HCIR)—which aims to deliver value-driven solutions to medical technology companies, healthcare delivery systems, and investors worldwide—has announced its global launch.
HCIR was formed by the merger of Healthcare Insights and Inroad Medical and is a partnership of clinicians and allied specialists dedicated to accelerating the goals and milestones of medical device companies, investors, and healthcare systems. A press release details that HCIR partners use their deep experience as clinicians, investigators, inventors, entrepreneurs, and healthcare system leaders to develop the most efficient process possible to achieve their clients’ goals.
HCIR’s founding partners are Gary Ansel, David Deaton, Michael R Jaff, Peter Schneider, Steve Cagnetta, and Craig McChesney.
“Any new medical device seeking its place in today’s healthcare environment must demonstrate tangible value to patients, clinicians, and healthcare delivery systems,” commented Schneider. “Our team of experts has deep experience in almost every aspect of healthcare innovation and delivery.”
Ansel added: “HCIR crafts unique solutions for each client to avoid pitfalls, save time and money, and maximise value. These services include a comprehensive review of the technology, clinical strategy, regulatory pathway, reimbursement environment, marketing research, and provider uptake analysis.”
HCIR states that it seeks clients who are interested in an integrated partnership from inception through completion, and offers its services to medical device companies, healthcare delivery systems, and MedTech investors in the USA, Europe, and Asia.
